Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE)

Abstract

We studied IgG and IgM anticardiolipin antibodies (aCL) by an ELISA method in 80 Mexican systemic lupus erythematosus (SLE) patients and 378 of their first degree relatives. Sixty five percent of SLE patients and 16% of their relatives were positive for aCL. We also determined allele and haplotype frequencies of Major Histocompatibility Complex (MHC) genes (classes I, II and III) in both patients and relatives. MHC allele and haplotype frequencies of aCL positive and negative individuals were compared to those of normal ethnically matched controls. SLE patients with aCL had statistically significant increased corrected frequencies of HLA-DR3 (pC = 0.04, RR = 2.78); DR7 (pC = 0.005), RR = 3.42) and DQ2 (pC = 0.003, RR = 2.58) antigens. Their first degree relatives positive for aCL also had increased frequency of HLA-DR7 but it did not remain significant after correcting the P value. On the other hand, SLE patients negative for aCL had a moderate increased frequency of DR3 and DQ2 but not of DR7. These results suggest that DR7 associates with the presence of aCL. The distribution of MHC alleles in SLE patients positive for aCL resembles that found in their aCL positive first degree relatives.

Since the presence of the antibody is not sufficient to predict a clinical outcome, we studied those patients with reliable clinical data regarding the presence of the antiphospholipid syndrome (aPLS). SLE patients with aPLS had significantly increased frequency of DR7 (pC = 0.004), as did those with probable aPLS (pC = 0.05), while the frequency of DR7 in SLE patients in the doubtful or negative aPLS categories was no different from normal controls.

These data support a possible role of DR7 in the development of aCL in SLE patients and their relatives and suggest a contribution of this class II MHC antigen to the development of aPLS within SLE.

Keywords

anticardiolipin antibodies antiphospholipid syndrome systemic lupus erythematosus major histocompatibility complex antiphospholipid antibodies autoimmunity

Get full access to this article

View all access options for this article.

References

Alarcón-Segovia D. et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989 ; 68: 353-365.

Love PE , Santoro SA Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990 ; 112: 682-698.

Conley CL , Hartman C. A haemorragic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus. J Clin Invest 1953; 31: 621-623.

Exner T. , Richard KA , Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns . Br J Hematol 1978; 40: 143-151.

Harris EN et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211-1214.

Loizou S. et al. Measurement of anticardiolipin antibodies by an enzime-linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol 1985; 62: 738-745.

Alarcon-Segovia D. , Sánchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-489.

Alarcón-Segovia D. Pathogenethic potential of antiphospholipid antibodies. J Rheumatol 1988; 15: 890-893.

Reinertsen JL et al. B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Eng J Med 1978; 299: 515-518.

10.

Gibofsky A. et al. Disease associations of the la-like human alloantigens associated with systemic lupus erythematosus. J Exp Med 1978; 148: 1728-1732.

11.

Bell DA , Maddison PJ Serologic subsets in systemic lupus erythematosus. An examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 1980; 23: 1268-1273.

12.

Ahearn JM et al. Interrelationships of HLA-DR, MB and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1031-1040.

13.

Gammon WR et al. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II associated. J Invest Dermatol 1982; 91: 228-232.

14.

Savi M. et al. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum 1988; 31: 1568-1570.

15.

McHugh NJ , Maddison PJ HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1623-1624.

16.

Arnett FC , Olsen ML , Anderson KL , Reveille JD Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 1991; 87: 1490-1495.

17.

Granados J. et al. The role of HLA-DR alleles and complotypes through the ethnic barrier in Mexican SLE patients. Lupus 1996; 5: 184-189.

18.

Vargas-Alarcón G. et al. Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients. Arthritis Rheum 1995; 38: 1340-1341.

19.

Alarcón-Segovia D. et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Seminars in Arthritis Rheum 1992; 21: 275-286.

20.

Weckmann AL et al. Frequency of HLA-A and HLA-B alleles in a Mexico City Mestizo group. Am J Hum Biology 1996; (in press).

21.

De Leo C. et al. Population analysis of class I and class II MHC loci obtained from family studies in Mexicans. (Submitted for publication).

22.

Granados J. et al. Frequency of complotypes in Mexicans . Immunología 1996; (in press).

23.

Gharavi AE , Harris EN , Asherson RA , Hughes Grv. Anticardiolipin antibodies: Isotype distribution and phospholipid specificity . Ann Rheum Dis 1987; 46: 1-6.

24.

Delezé M. , Oria CV , Alarcón-Segovia D. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies . J Rheumatol 1988; 15: 611-615.

25.

Boyum A. Isolation of leukocytes from human blood: further observations. Scand J Clin Lab Invest 1968; 97 (Suppl): 31.

26.

Terasaki PI , McClelland JD Microdroplet assay of human serum cytotoxins . Nature 1964; 204: 998.

27.

Bodmer JG , Pickbourne P. , Richards S. Ia serology. In: Bodmer WF , Barchelor JR , Bodmer JG , Festenstein H , Morris PJ (Eds) Histocompatibility Testing 1977. Munksgaard: Copenhagen, 1977.

28.

Alper CA , Boenisch T. , Watson L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med 1972; 135: 68-80.

29.

Awdeh ZL , Alper CA Inherited structural polymorphism of the forth component of human complement . Proc Natl Acad Sci USA 1980; 77: 3576-3580.

30.

Alper CA Inherited structural polymorphism in human C2: evidence for linkage between C2 and Bf. J Exp Med 1976; 144: 1111-1115.

31.

32.

Hartung K. et al. MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study. SLE study group. Autoimmunity 1992; 13: 95-99.

33.

Cabiedes J. , Cabral AP , Alarcón-Segovia D. Clinical manifestations of the antiphospholipid syndrome in systemic lupus erythematosus patients associated more strongly with anti-beta 2 glycoprotein-1 than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-1906.

34.

Goldstein R. , Smith CD , Sengar Dps. MHC class II studies of primary antiphospholipid antibody (APLA) syndrome and of serum antiphospholipid antibodies in systemic lupus erythematosus (SLE). Arth Rheum 1990 ; 33: S125 (abstract).

35.

Vargas-Alarcón G. et al. Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients. Arthritis and Rheumatism 1995; 38: 1340-1343.

36.

Camps MT et al. Immunogenetics characteristics of lupus patients with secondary antiphospholipid syndrome. Lupus 1995; 4: 22S (abstract).

37.

Wilson WA , Perez MC , Michalski JP , Armatis PE Cardiolipin antibodies and null alleles of C4 in Black Americans with systemic lupus erythematosus. J Rheumatology 1988; 15: 1768-1772.

38.

Petri M. , Watson R. , Winkelstein JA , McLean RH Clinical expression of systemic lupus erythematosus in patients with C4A deficiency . Medicine 1993; 72: 236-244.

39.

Lisker R. et al. Gene frequencies and admixture estimates in a Mexican city population . Am J Physical Anthropol 1986; 71: 203-207.

40.

Lisker R. , Pérez-Briceño R. , Granados J. , Babinksy V. Gene frequencies and admixture estimates in the State of Puebla, Mexico . Am J Physical Anthropol 1988; 76: 331-335.

41.

Lisker R. et al. Gene frequencies and admixture estimates in four Mexican Urban Centers. Hum Biology 1990; 62: 791-801.